0001562180-24-005606.txt : 20240703 0001562180-24-005606.hdr.sgml : 20240703 20240703172730 ACCESSION NUMBER: 0001562180-24-005606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Monica R. CENTRAL INDEX KEY: 0001978347 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 241100992 MAIL ADDRESS: STREET 1: 700 PARK OFFICES STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER NAME: FORMER CONFORMED NAME: Thomas Monica DATE OF NAME CHANGE: 20230518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-07-01 false 0001560241 G1 Therapeutics, Inc. GTHX 0001978347 Thomas Monica R. 700 PARK OFFICES DRIVE, SUITE 200 RESEARCH TRIANGLE PARK NC 27709 false true false false Chief Legal & People Officer false Common Stock 2024-07-01 4 A false 35000.00 0.00 A 144825.00 D Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer common stock. Represents (i) 6,850 shares of common stock; (ii) 37,500 RSUs from award granted on May 22, 2023; (iii) 27,975 RSUs from award granted on January 3, 2024; (iv) 37,500 RSUs from award granted on March 20, 2024; and (v) 35,000 RSUs from award granted on July 1, 2024. /s/ Monica Thomas 2024-07-03